# Ye Liu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ye-liu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 50 |
| Field | Nanoparticle-Based Drug Delivery |
| h-index | 4 |
| i10-index | 3 |
| Last Known Institution | Shihezi University |
| OpenAlex ID | https://openalex.org/A5083093863 |
| ORCID iD | 0009-0005-3116-474X |
| Works | 23 |

## Researcher papers

- [Study on the Efficacy of Sacubitril/Valsartan in Patients with Heart Failure with Preserved Ejection Fraction Undergoing Peritoneal Dialysis](https://scholariq.org/papers/study-on-the-efficacy-of-sacubitril-valsartan-in-patients-with-heart-failure/)
- [Trend of albumin nanoparticles in oncology: a bibliometric analysis of research progress and prospects](https://scholariq.org/papers/trend-of-albumin-nanoparticles-in-oncology-a-bibliometric-analysis-of-research/)
- [Independent risk factors for depression in older adult patients receiving peritoneal dialysis for chronic kidney disease](https://scholariq.org/papers/independent-risk-factors-for-depression-in-older-adult-patients-receiving/)
- [Unmasking hidden metastasis: A case report of gastrointestinal metastasis detected a decade after breast cancer diagnosis](https://scholariq.org/papers/unmasking-hidden-metastasis-a-case-report-of-gastrointestinal-metastasis/)
- [Extremely rare mucinous adenocarcinoma of the small bowel causing bilateral metastatic Kukenberg tumors of the ovaries: A case report](https://scholariq.org/papers/extremely-rare-mucinous-adenocarcinoma-of-the-small-bowel-causing-bilateral/)
- [P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer](https://scholariq.org/papers/p082-cbcsg-10-the-addition-of-capecitabine-to-adjuvant-chemotherapy-in-triple/)
- [A phase III adjuvant vinorelbine plus cisplatin (NP) versus NP plus endostar (NPE) in patients (pts) with completely resected stage IB-IIIA non-small cell lung cancer (NSCLC): An interim preliminary result.](https://scholariq.org/papers/a-phase-iii-adjuvant-vinorelbine-plus-cisplatin-np-versus-np-plus-endostar-npe/)
- [Causal association between artificial sweeteners and risk of 15 tumors: A 2-way 2-sample Mendelian randomization analysis](https://scholariq.org/papers/causal-association-between-artificial-sweeteners-and-risk-of-15-tumors-a-2-way-2/)
- [Causal relationship between endometrial cancer and risk of breast cancer: A 2-sample Mendelian randomization study](https://scholariq.org/papers/causal-relationship-between-endometrial-cancer-and-risk-of-breast-cancer-a-2/)
- [The hidden malignancy: A case of descending colon cancer presenting with incarcerated inguinal hernia](https://scholariq.org/papers/the-hidden-malignancy-a-case-of-descending-colon-cancer-presenting-with/)

## Researcher topics

- [Nanoparticle-Based Drug Delivery](https://scholariq.org/topics/nanoparticle-based-drug-delivery/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Diverticular Disease and Complications](https://scholariq.org/topics/diverticular-disease-and-complications/)

## Researcher university

- [Shihezi University](https://scholariq.org/institutions/shihezi-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.